Skip to main navigation Skip to search Skip to main content

Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review

  • Rob M. A. de Bie*
  • , Regina Katzenschlager
  • , Bart E. K. S. Swinnen
  • , Marina Peball
  • , Shen-Yang Lim
  • , Tiago A. Mestre
  • , Santiago Perez Lloret
  • , Miguel Coelho
  • , Camila Aquino
  • , Ai Huey Tan
  • , Veronica Bruno
  • , Joke M. Dijk
  • , Beatrice Heim
  • , Chin-Hsien Lin
  • , Linda Azevedo Kauppila
  • , Irene Litvan
  • , René Spijker
  • , Klaus Seppi
  • , João Costa
  • , Cristina Sampaio
  • Susan H. Fox, Monty A. Silverdale
*Corresponding author for this work
  • Amsterdam UMC - University of Amsterdam
  • Klinik Donaustadt
  • KU Leuven
  • Innsbruck Medical University
  • University of Malaya
  • University of Ottawa
  • Pontificia Universidad Católica Argentina Santa María de los Buenos Aires - UCA
  • Universidad de Buenos Aires
  • Centro de Estudos Egas Moniz
  • University of Calgary
  • National Taiwan University
  • CNS – Campus Neurológico
  • University of California at San Diego
  • Amsterdam UMC
  • Kufstein County Hospital
  • University of Lisbon
  • CHDI Foundation, Inc.
  • Faculdade de Medicina de Lisboa (FMUL)
  • Toronto Western Hospital
  • University of Manchester

Research output: Contribution to journalReview articleAcademicpeer-review

91 Downloads (Pure)

Abstract

Objective: To update evidence-based medicine recommendations for treating motor fluctuations of Parkinson's disease (PD). Background: The International Parkinson and Movement Disorder Society (MDS) Evidence Based Medicine in Movement Disorders Committee recommendations for the treatments of PD were first published in 2002 and regularly updated. The current review uses a new methodology, including the Cochrane Risk of Bias tool and a modified version of GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). Methods: On January 1, 2023, a literature search was conducted without date limit in the MEDLINE, Embase, and Cochrane databases using the following search terms: Parkinson disease, levodopa and, for the Embase database, randomized controlled trial (RCT). The inclusion criteria for studies were: patients with PD, on oral levodopa therapy, experiencing motor fluctuations, investigating an intervention that was (commercially) available in at least one country, study design RCT, and with a follow-up duration of at least 3 months. Results: A total of 102 studies were included. Levodopa extended release, pramipexole immediate release and extended release, ropinirole immediate release, rotigotine, opicapone, safinamide, and bilateral subthalamic nucleus deep brain stimulation (DBS) were assessed as efficacious, and continuous intestinal levodopa infusion, continuous subcutaneous levodopa, continuous subcutaneous apomorphine, ropinirole prolonged release, ropinirole patch, entacapone, rasagiline, istradefylline, amantadine extended release, zonisamide, bilateral globus pallidus DBS, and pallidotomy were assessed as likely efficacious for the treatment of motor fluctuations in people with PD who are already being treated with levodopa. Conclusions: There are several treatment options that can improve motor fluctuations in PD. These recommendations will assist physicians and patients in determining which intervention to use.

Original languageEnglish
Pages (from-to)776-794
Number of pages19
JournalMovement disorders
Volume40
Issue number5
Early online date2025
DOIs
Publication statusPublished - May 2025

Keywords

  • Parkinson's disease
  • motor response fluctuations
  • randomized controlled trial
  • systematic review
  • treatments

Fingerprint

Dive into the research topics of 'Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review'. Together they form a unique fingerprint.

Cite this